Infinite Possibilities Made Possible

The validation engine for AI discovery in 4 days.

Start Validation

GenScript Life Science
Research Grant 2026

IGNITE YOUR
SCIENTIFIC
POSSIBILITIES

Apply Now

Products & Services

GenScript offers highly customizable and tailor-made solutions for your research needs. Learn more about our full service portfolios by clicking on the icons below. Reach out to our Ph.D. level customer support personnel for more information today!

Gene
Services

100% sequence-verified clonal gene
99.99% delivery rate
Largest gene provider in the US since 2008

Protein
Services

5 BDs for HT gene-to-antibody
10 BDs for gram-level expression
70+ BsAb formats produced

mRNA
Services

From Design to Delivery: mRNA, saRNA, circRNA & LNP Formulation

CRISPR
Services

To achieve the best genome editing efficiency in any cell!

Peptide
Services

Quantity from mg to kg, >300 available modifications, Deliver as fast as 5 days

Oligo
Services

Up to 218nt DNA oligo and 266nt RNA oligo
Up to kg level
ISO 13485 available
High quality & consistency

Reagent Antibody
Services

Comprehensive and Custom Antibody Development for Research and Diagnostics

Catalog
Products

Reliable reagents & optimized kits with next-day shipping

Event
Webinar

Australia

Boston

Switzerland

High-Titer Lentivirus Solutions in 5 Days: Break Production Barriers for CGT

September 4, 2025
10:00 AM EDT (NA) / 7:00 AM PDT (NA) / 3:00 PM BST (UK) / 4:00 PM CEST (EU-Central)

: Chuanxin Liu, PhD

Head of Viral Vector R&D, GenScript

How Cell-free mRNA Templates Support Faster Research with High-quality and Quick Turnaround?

Speaker: Andrew Tsao, Global Product Manager, GenScript
Date: August 22, 2025
Time: 1:00 pm EDT (NA) / 6:00 pm BST (UK) / 7:00 pm CEST (EU-Central)

Enhance productivity and purity in next-generation bispecific antibody manufacturing

Speaker: Dr. Heng Tai Liew, Senior Protein Scientist, GenScript Biotech
Date: July 14, 2025
Time: 15:00 BST | 16:00 CEST | 10:00 EDT | 7:00 PDT

Unlocking the Future of Gene Editing: Key Concepts and Breakthroughs in CRISPR Prime Editing

Speaker: Juliana Campo Garcia, Field Application Scientist, GenScript
Date: May 9th 2025
Time: 9:00 am EDT (NA) / 2:00pm BST (UK) / 3:00pm CEST (EU-Central)

Real Customer Stories

: Sergej Kudruk

Northwestern University

GenScript delivered great service with their high-speed production capabilities of round-the-clock responsiveness, which played a crucial role in expediting our project.

: Dr. Mahdi Zeraati

University of Sydney

I am very pleased with the quality and reliability of GenScript’s services. We have used their IVT mRNA synthesis, FLASH gene synthesis, and TurboCHO antibody production platforms across several projects, and each has consistently met our expectations. Notably, GenScript successfully synthesized a challenging, repeat-rich gene that other providers declined to undertake, demonstrating their technical capability and commitment to supporting complex research needs. Turnaround times were acceptable, and technical support was both responsive and knowledgeable. I would confidently recommend GenScript to researchers seeking high-quality solutions in molecular biology and protein production

: Sam Sternberg

Columbia University

GenScript has been invaluable when our research required access to custom synthetic gene sequences, and when outsourcing laborious and time-consuming cloning challenges freed up our efforts to be applied elsewhere.

: MariaMorello Miravet

Karolinska Institutet

We are very pleased with the editing efficiency using base editors from GenScript, we got up to 100% KO!

: Dr Eleanor Williams

Centre for Medicines Development

GenScript are very responsive and helpful when it comes to helping with the design of the plasmid that I needed. They had excellent technical knowledge and helped me make sure that the plasmids I ordered were actually what I wanted and did what I needed.

: Feng Qian

University of Maryland

GenScript's team possesses extensive knowledge and technical proficiency in antibody development, making them an ideal collaborator for creating specialized antibodies targeted at a complex protein like PC1.

: Alexander Marson, MD, PhD

Professor Medicine, Director of Gladstone-UCSF Institute of Genomic Immunology

We have a requirement for long single-stranded DNA that can be used in a clinical manufacturing process, and this is where we benefited from a wonderful collaboration with GenScript.

: Kristian Hargadon

Hampden-Sydney College

I have used GenCRISPR™ gRNA/Cas9 Plasmids from GenScript on numerous occasions and always been pleased with the turnaround time from order to delivery. In all cases, I've been able to achieve high efficiency gene editing. I will certainly be continuing to go through GenScript for my gene editing needs in the future.

: Adnan Dibas

NanoScope Technologies LLC

I have ordered many products from GenScript (plasmids (more than 15), AAV2 products, and contracted them to produce mutants of plasmids. Their services are amazing and on time. I recommend GenScript for any colleague.

: Possu Huang

Stanford University

We build computational models of proteins based on design hypotheses. The fact that you can cover exactly the distribution, positions, and mutation sites to test our hypotheses, not only streamlines the experiments but also informs our understanding better than using degenerate codons.

: Jack Castelli

Fred Hutchinson Cancer Center

The people at GenScript have been tremendously helpful in providing materials for our lab. We've been able to test novel CRISPR systems such as prime editing and PASSIGE in a timely manner thanks to their work. I would recommend their services for your editing needs.

: Sergej Kudruk

Northwestern University

GenScript delivered great service with their high-speed production capabilities of round-the-clock responsiveness, which played a crucial role in expediting our project.

: Sam Sternberg

Columbia University

GenScript has been invaluable when our research required access to custom synthetic gene sequences, and when outsourcing laborious and time-consuming cloning challenges freed up our efforts to be applied elsewhere.

News & Blogs

Unveiling the Potential of GLP-1 Receptor Agonists and Multi-Target Therapies

Author: Mina Wang
Senior Scientist ·Peptide R&D Department

CRISPR Screening to Optimize CAR Therapies | GenScript

Author: Rosa Moreno, PhD
Sr. Content Marketing Manager

Mastering siRNA Design: Steps to Achieve Precision Gene Silencing/GenScript

Author: Junjie Xu
Senior Scientist

Engineered NK cells, off-the-shelf solution | GenScript

Author: Rosa Moreno, PhD
Sr. Content Marketing Manager

Multiplex Editing T Cells with BE and Cas12 | GenScript

Author: Dr. Wanjia Zeng
Senior Scientist of Gene Editing

Challenges in Neoantigen Peptide Manufacturing | GenScript

Author: Gordon Li
Director of Peptide and R&D Department

Drog To Switch